Michael E. Steffey

1.2k total citations
18 papers, 1.0k citations indexed

About

Michael E. Steffey is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Michael E. Steffey has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Oncology. Recurrent topics in Michael E. Steffey's work include Protein Kinase Regulation and GTPase Signaling (7 papers), Receptor Mechanisms and Signaling (5 papers) and Melanoma and MAPK Pathways (4 papers). Michael E. Steffey is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (7 papers), Receptor Mechanisms and Signaling (5 papers) and Melanoma and MAPK Pathways (4 papers). Michael E. Steffey collaborates with scholars based in United States and United Kingdom. Michael E. Steffey's co-authors include Edward F. Nemeth, Lance G. Hammerland, Bradford C. Van Wagenen, Eric G. DelMar, Manuel F. Balandrin, Matthew B. Soellner, Christel C. Fox, Kristoffer Brandvold, Robert G. MacKenzie and Arlene M. Manelli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Michael E. Steffey

18 papers receiving 973 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael E. Steffey United States	14	593	323	224	189	154	18	1.0k
Eric G. DelMar United States	10	536 0.9×	479 1.5×	145 0.6×	240 1.3×	215 1.4×	13	1.1k
A. Thomsen United States	17	1.1k 1.9×	128 0.4×	595 2.7×	99 0.5×	93 0.6×	32	1.5k
Masahiro Kinuta Japan	11	637 1.1×	238 0.7×	122 0.5×	48 0.3×	51 0.3×	39	1.1k
Viswanathan Raghuram United States	20	1.0k 1.7×	58 0.2×	91 0.4×	66 0.3×	63 0.4×	41	1.4k
Kun Cao China	14	464 0.8×	37 0.1×	104 0.5×	27 0.1×	63 0.4×	22	847
N. E. Owen United States	19	811 1.4×	36 0.1×	163 0.7×	40 0.2×	60 0.4×	31	1.2k
Charles Woodard United States	9	575 1.0×	43 0.1×	298 1.3×	33 0.2×	66 0.4×	11	791
Roberto Buccafusca United States	14	305 0.5×	77 0.2×	95 0.4×	33 0.2×	33 0.2×	23	710
A.D. Perris Canada	20	401 0.7×	34 0.1×	54 0.2×	60 0.3×	131 0.9×	40	849
Ruth A. Senter United States	15	916 1.5×	86 0.3×	287 1.3×	20 0.1×	21 0.1×	17	1.2k

Countries citing papers authored by Michael E. Steffey

Since Specialization

Citations

This map shows the geographic impact of Michael E. Steffey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Steffey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Steffey more than expected).

Fields of papers citing papers by Michael E. Steffey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Steffey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Steffey. The network helps show where Michael E. Steffey may publish in the future.

Co-authorship network of co-authors of Michael E. Steffey

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Steffey. A scholar is included among the top collaborators of Michael E. Steffey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Steffey. Michael E. Steffey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Brandvold, Kristoffer, et al.. (2015). Exquisitely Specific Bisubstrate Inhibitors of c-Src Kinase. ACS Chemical Biology. 10(6). 1387–1391. 19 indexed citations

2.

Kwarcinski, Frank E., Michael E. Steffey, Christel C. Fox, & Matthew B. Soellner. (2015). Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration. ACS Medicinal Chemistry Letters. 6(8). 898–901. 14 indexed citations

3.

Breen, Meghan E., et al.. (2014). Substrate Activity Screening with Kinases: Discovery of Small‐Molecule Substrate‐Competitive c‐Src Inhibitors. Angewandte Chemie International Edition. 53(27). 7010–7013. 19 indexed citations

4.

Breen, Meghan E., et al.. (2014). Substrate Activity Screening with Kinases: Discovery of Small‐Molecule Substrate‐Competitive c‐Src Inhibitors. Angewandte Chemie. 126(27). 7130–7133. 4 indexed citations

5.

Steffey, Michael E., et al.. (2013). Development of a Chimeric c-Src Kinase and HDAC Inhibitor. ACS Medicinal Chemistry Letters. 4(8). 779–783. 44 indexed citations

6.

Kwarcinski, Frank E., Christel C. Fox, Michael E. Steffey, & Matthew B. Soellner. (2012). Irreversible Inhibitors of c-Src Kinase That Target a Nonconserved Cysteine. ACS Chemical Biology. 7(11). 1910–1917. 38 indexed citations

7.

Brandvold, Kristoffer, Michael E. Steffey, Christel C. Fox, & Matthew B. Soellner. (2012). Development of a Highly Selective c-Src Kinase Inhibitor. ACS Chemical Biology. 7(8). 1393–1398. 108 indexed citations

8.

Steffey, Michael E., et al.. (2003). Cell Surface Expression of the Melanocortin-4 Receptor Is Dependent on a C-terminal Di-isoleucine Sequence at Codons 316/317. Journal of Biological Chemistry. 278(18). 15935–15940. 46 indexed citations

9.

Nemeth, Edward F., Michael E. Steffey, Lance G. Hammerland, et al.. (1998). Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proceedings of the National Academy of Sciences. 95(7). 4040–4045. 485 indexed citations

10.

Nemeth, Edward F., Michael E. Steffey, & John Fox. (1996). The parathyroid calcium receptor: a novel therapeutic target for treating hyperparathyroidism. Pediatric Nephrology. 10(3). 275–279. 33 indexed citations

11.

Nemeth, Edward F., Michael E. Steffey, & John Fox. (1996). The parathyroid calcium receptor: a novel therapeutic target for treating hyperparathyroidism. Pediatric Nephrology. 10(3). 275–279. 2 indexed citations

12.

Frail, D E, Arlene M. Manelli, David G. Witte, et al.. (1993). Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization.. Molecular Pharmacology. 44(6). 1113–1118. 36 indexed citations

13.

MacKenzie, Robert G., Michael E. Steffey, Arlene M. Manelli, Nancy J. Pollock, & Donald E. Frail. (1993). A D1/D2 chimeric dopamine receptor mediates a D1 response to a D2‐selective agonist. FEBS Letters. 323(1-2). 59–62. 14 indexed citations

14.

Steffey, Michael E., Ellen Roberts, Donald E. Frail, John W. Kebabian, & Robert G. MacKenzie. (1993). Further characterization of the D2 dopamine receptor expressed in MMQ cells. Biochemical Pharmacology. 46(4). 747–751. 7 indexed citations

15.

Pollock, Nancy J., et al.. (1992). Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation.. Journal of Biological Chemistry. 267(25). 17780–17786. 83 indexed citations

16.

Steffey, Michael E., Gretchen L. Snyder, Ronald W. Barrett, et al.. (1991). Dopamine D1 receptor stimulation of cyclic AMP accumulation in COS-1 cells. European Journal of Pharmacology Molecular Pharmacology. 207(4). 311–317. 5 indexed citations

17.

Barrett, Ronald W., et al.. (1989). Type-A cholecystokinin binding sites in cow brain: characterization using (-)-[3H]L364718 membrane binding assays.. Molecular Pharmacology. 36(2). 285–290. 29 indexed citations

18.

Barrett, Ronald W., et al.. (1989). Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis.. Molecular Pharmacology. 35(4). 394–400. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact